World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
57
Citations
11077
World Ranking
3592
National Ranking
77

Pieter Leyssen publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Pieter Leyssen sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 234 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Pieter Leyssen D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Pieter Leyssen sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 57 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Pieter Leyssen is affiliated with the Rega Institute for Medical Research in Belgium. Their research primarily focuses on medicine, with a significant contribution to infectious diseases, epidemiology, molecular biology, computational theory and mathematics, and public health, environmental and occupational health.

The main topics of Pieter Leyssen's work include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Computational Drug Discovery Methods
  • Viral Infections and Immunology Research
  • Mosquito-borne diseases and control
  • Viral gastroenteritis research and epidemiology
  • Animal Virus Infections Studies

Frequently publishing in scientific venues, Pieter Leyssen's work appears often in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Antiviral Research
  • Molecules
  • Nature Communications
  • Journal of Medicinal Chemistry

The scientist has collaborated multiple times with several coauthors, including:

  • Johan Neyts
  • Dirk Jochmans
  • Steven De Jonghe
  • Laura Vangeel
  • Winston Chiu

Pieter Leyssen's notable recent publications are:

  • "α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment," 2020, Journal of Medicinal Chemistry
  • "Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern," 2022, Antiviral Research
  • "STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters," 2020, Nature Communications
  • "Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen," 2021, ACS Pharmacology & Translational Science
  • "The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model," 2021, EBioMedicine

Best Publications

  • Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

    Unknown

  • α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment

    Linlin Zhang;Daizong Lin;Yuri Kusov;Yong Nian

  • Bioactivity-Based Molecular Networking for the Discovery of Drug Leads in Natural Product Bioassay-Guided Fractionation

    Louis-Félix Nothias;Louis-Félix Nothias;Louis-Félix Nothias;Mélissa Nothias-Esposito;Mélissa Nothias-Esposito;Ricardo da Silva;Ricardo da Silva;Mingxun Wang;Mingxun Wang

  • The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.

    Pieter Leyssen;Jan Balzarini;Erik De Clercq;Johan Neyts

  • Perspectives for the Treatment of Infections with Flaviviridae

    P Leyssen;E De Clercq;J Neyts

  • STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.

    Robbert Boudewijns;Robbert Boudewijns;Hendrik Jan Thibaut;Hendrik Jan Thibaut;Suzanne J. F. Kaptein;Suzanne J. F. Kaptein;Rong Li

  • Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein.

    Jeroen R.P.M. Strating;Jeroen R.P.M. Strating;Lonneke van der Linden;Lonneke van der Linden;Lucian Albulescu;Lucian Albulescu;Joëlle Bigay

  • Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral

    Leen Delang;Nidya Segura Guerrero;Ali Tas;Gilles Quérat

  • Molecular strategies to inhibit the replication of RNA viruses

    Pieter Leyssen;Erik De Clercq;Johan Neyts

  • Poly(I)-Poly(C12U) but Not Ribavirin Prevents Death in a Hamster Model of Nipah Virus Infection

    M. C. Georges-Courbot;H. Contamin;C. Faure;P. Loth

  • Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen

    Maria Kuzikov;Elisa Costanzi;Jeanette Reinshagen;Francesca Esposito

  • Favipiravir (T-705) inhibits in vitro norovirus replication.

    J Rocha-Pereira;Dirk Jochmans;Kai Dallmeier;Pieter Leyssen

  • A Novel, Broad-Spectrum Inhibitor of Enterovirus Replication That Targets Host Cell Factor Phosphatidylinositol 4-Kinase IIIβ

    Hilde M van der Schaar;Pieter Leyssen;Hendrik Jan Thibaut;Armando De Palma

  • 3C protease of enterovirus 68: Structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses

    Jinzhi Tan;Shyla George;Yuri Kusov;Markus Perbandt

  • The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model.

    Rana Abdelnabi;Caroline S. Foo;Suzanne J.F. Kaptein;Xin Zhang

  • Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development.

    Leen Delang;Jan Paeshuyse;Inge Vliegen;Pieter Leyssen

  • Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus

    Marcella Bassetto;Tine De Burghgraeve;Leen Delang;Alberto Massarotti

  • Novel 1,2,4-triazole and imidazole derivatives of l-ascorbic and imino-ascorbic acid: Synthesis, anti-HCV and antitumor activity evaluations

    Karlo Wittine;Maja Stipković Babić;Damjan Makuc;Janez Plavec

  • The anti-yellow fever virus activity of ribavirin is independent of error-prone replication.

    Pieter Leyssen;Erik De Clercq;Johan Neyts

  • Coumarin-purine ribofuranoside conjugates as new agents against hepatitis C virus.

    Jih Ru Hwu;Jih Ru Hwu;Shu-Yu Lin;Shwu-Chen Tsay;Erik De Clercq

  • Prostratin and 12-O-tetradecanoylphorbol 13-acetate are potent and selective inhibitors of Chikungunya virus replication.

    Mélanie Bourjot;Leen Delang;Van Hung Nguyen;Johan Neyts

Frequent Co-Authors

Johan Neyts
Johan Neyts Rega Institute for Medical Research
Erik De Clercq
Erik De Clercq Rega Institute for Medical Research
Bruno Canard
Bruno Canard Aix-Marseille University
Françoise Guéritte
Françoise Guéritte Institut de Chimie des Substances Naturelles
Christophe Pannecouque
Christophe Pannecouque Rega Institute for Medical Research
Frank J. M. van Kuppeveld
Frank J. M. van Kuppeveld Utrecht University
Bruno Coutard
Bruno Coutard Aix-Marseille University
Jan Balzarini
Jan Balzarini KU Leuven
Jih Ru Hwu
Jih Ru Hwu National Tsing Hua University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open doors to diverse career opportunities. Fields such as health information management are increasingly important in healthcare, combining data management with medical knowledge. Those curious about the financial prospects can learn more about the health information management bachelor degree salary to understand potential earnings.

Choosing the right program is crucial, especially with growing demand for accredited credentials. Prospective students should consider the best online cahiim accredited health information management degree programs to ensure quality education that meets industry standards.

For those seeking quicker entry into healthcare administration, the best fastest online medical billing and coding certificate programs offer efficient training pathways. These certificates provide essential skills for managing healthcare documentation and claims processing.

Additionally, advances in technology have broadened options for healthcare education. Students can explore various alternatives by reviewing what medical degrees can i get online to find programs that fit their career goals while studying remotely.

Best Scientists Citing Pieter Leyssen

Trending Scientists

Recently Published Articles